|
|
|
|
Vol. 10, Issue 1, 49-54, January 2000
LETTER
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
M. Mrug, R. Li, X. Cui, T. R. Schoeb, G. A. Churchill, and L. M. Guay-Woodford Kinesin Family Member 12 Is a Candidate Polycystic Kidney Disease Modifier in the cpk Mouse J. Am. Soc. Nephrol., April 1, 2005; 16(4): 905 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Cantrell, S. E. Owens, R. L. Chandler, D. C. Airey, K. M. Bradley, J. R. Smith, and E. M. Southard-Smith Interactions between Sox10 and EdnrB modulate penetrance and severity of aganglionosis in the Sox10Dom mouse model of Hirschsprung disease Hum. Mol. Genet., October 1, 2004; 13(19): 2289 - 2301. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Guay-Woodford Murine models of polycystic kidney disease: molecular and therapeutic insights Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1034 - F1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Devuyst, A. Persu, and M.-T. Vo-Cong Autosomal dominant polycystic kidney disease: modifier genes and endothelial dysfunction Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2211 - 2215. [Full Text] [PDF] |
||||
![]() |
S. Liu, W. Lu, T. Obara, S. Kuida, J. Lehoczky, K. Dewar, I. A. Drummond, and D. R. Beier A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish Development, March 14, 2003; 129(24): 5839 - 5846. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tripodis and P. Demant Genetic Analysis of Three-dimensional Shape of Mouse Lung Tumors Reveals Eight Lung Tumor Shape-Determining (Ltsd) Loci That Are Associated with Tumor Heterogeneity and Symmetry Cancer Res., January 1, 2003; 63(1): 125 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Bihoreau, N. Megel, J. H. Brown, B. Kranzlin, L. Crombez, Y. Tychinskaya, J. Broxholme, S. Kratz, V. Bergmann, S. Hoffman, et al. Characterization of a major modifier locus for polycystic kidney disease (Modpkdr1) in the Han:SPRD(cy/+) rat in a region conserved with a mouse modifier locus for Alport syndrome Hum. Mol. Genet., September 1, 2002; 11(18): 2165 - 2173. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nurnberger, R. L. Bacallao, and C. L. Phillips Inversin Forms a Complex with Catenins and N-Cadherin in Polarized Epithelial Cells Mol. Biol. Cell, September 1, 2002; 13(9): 3096 - 3106. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. SOMMARDAHL, M. COTTRELL, J. E. WILKINSON, R. P. WOYCHIK, and D. K. JOHNSON Phenotypic variations of orpk mutation and chromosomal localization of modifiers influencing kidney phenotype Physiol Genomics, December 21, 2001; 7(2): 127 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Reifsnyder, G. Churchill, and E. H. Leiter Maternal Environment and Genotype Interact to Establish Diabesity in Mice Genome Res., October 1, 2000; 10(10): 1568 - 1578. [Abstract] [Full Text] |
||||
![]() |
L. M. Guay-Woodford, W. J. Green, J. R. Lindsey, and D. R. Beier Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated Hum. Mol. Genet., March 22, 2000; 9(5): 769 - 778. [Abstract] [Full Text] [PDF] |
||||